These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5466919)

  • 61. [Inhibitory action of glucocorticoids on glucose-6-phosphate dehydrogenase activty. A screening of antipsoriatic effects (author's transl)].
    Raab W; Siber H
    Arch Dermatol Forsch; 1974 Jun; 249(4):357-66. PubMed ID: 4407433
    [No Abstract]   [Full Text] [Related]  

  • 62. Bioavailability of topical steroids.
    Barry BW
    Dermatologica; 1976; 152 Suppl 1():47-65. PubMed ID: 955238
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Age-dependent differences in the pharmacodynamic effect of topically applied Corticosteroids].
    Koch EM; Ott R; Koehler CO
    Arzneimittelforschung; 1986 Oct; 36(10):1540-4. PubMed ID: 3814215
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 65. [Optimal measurement technic for the vasoconstrictor effect of corticosteroids. Comparative studies with reflection photometry and flow measurement].
    Gloor M; Sprenger HJ; Priebe L
    Dermatol Monatsschr; 1979 Sep; 165(9):665-9. PubMed ID: 527746
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Corticosteroids and adrenal function.
    JAMA; 1969 Sep; 209(11):1713. PubMed ID: 5820170
    [No Abstract]   [Full Text] [Related]  

  • 67. [Comparison of the effectiveness of locally administered corticosteroids].
    Semrádová V; Horácek J
    Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
    [No Abstract]   [Full Text] [Related]  

  • 68. The physical, animal and human pharmacologic, and toxicologic properties of desonide, a new, topically active, antiinflammatory steroid.
    Phillips BM; Sanen FJ; Leeling JL; Hammes TL; Hartnagel RE; Sancilio LF; Lorenzetti OJ; Kraus PJ
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):522-37. PubMed ID: 5143593
    [No Abstract]   [Full Text] [Related]  

  • 69. The evaluation of several topical corticosteroid preparations in the blanching test.
    Coldman MF; Lockerbie L; Laws EA
    Br J Dermatol; 1971 Oct; 85(4):381-7. PubMed ID: 5125641
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of corticosteroids on fibroblast functions.
    Berliner DL; Nabors CJ
    J Reticuloendothel Soc; 1967 Jul; 4(4):284-313. PubMed ID: 6056840
    [No Abstract]   [Full Text] [Related]  

  • 71. Percutaneous steroid absorption in anhidrosis.
    Solomon LM; Altman AT
    J Invest Dermatol; 1969 Dec; 53(6):454-7. PubMed ID: 5361579
    [No Abstract]   [Full Text] [Related]  

  • 72. Penetration of drugs through the skin.
    Stoughton RB
    Dermatologica; 1976; 152 Suppl 1():27-36. PubMed ID: 133842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allergic reactions to topical corticosteroids or their vehicles.
    Fisher AA
    Cutis; 1983 Aug; 32(2):122, 129-32, 137. PubMed ID: 6225625
    [No Abstract]   [Full Text] [Related]  

  • 74. [Effects of tropical application of steroids on the skin].
    Tagami H
    Hifuka Kiyo; 1971 Feb; 66(1):1-45. PubMed ID: 5170320
    [No Abstract]   [Full Text] [Related]  

  • 75. [Quality control of prepared drug forms containing corticosteroids by physicochemical means. II. Spectrophotmetric determination of prednisolone and fluocinolone acetonide in ointments].
    Bobkova LN; Kazarinov NA
    Farm Zh; 1974; (1):59-63. PubMed ID: 4463033
    [No Abstract]   [Full Text] [Related]  

  • 76. [Comparative pharmacological activity of triamcinolone acetonide and of a new topical steroid: amcinonide, after percutaneous or oral administration (author's transl)].
    Wepierre J; Bogaievsky Y
    J Pharmacol; 1980; 11(4):449-62. PubMed ID: 7206733
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.
    Snyder DS; Greenberg RA
    J Invest Dermatol; 1974 Dec; 63(6):461-3. PubMed ID: 4430856
    [No Abstract]   [Full Text] [Related]  

  • 78. STEROIDS IN THE TREATMENT OF DERMATOSES.
    GOLDBERG LC
    Cinci J Med; 1963 Nov; 44():441-3. PubMed ID: 14084718
    [No Abstract]   [Full Text] [Related]  

  • 79. [Is the vasoconstrictor test suitable for comparing the effect of locally applied corticosteroids? An experimental study].
    Zaun H
    Arch Klin Exp Dermatol; 1966; 226(4):359-68. PubMed ID: 5987407
    [No Abstract]   [Full Text] [Related]  

  • 80. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.